San Diego Law Review

Library of Congress Authority File


Document Type



This Article examines and critiques pending Congressional proposals for the way we manage risk and focuses on the regulation of substances that are potentially carcinogenic. The author argues that the federal role in risk management of carcinogenic substances has grown along with the extent of public concern. The author reviews the current federal regulatory framework and then analyzes pending Congressional proposals for changes in federal risk management. The author concludes that recent legislative proposals for centralization of scientific fact-finding would not result in greater consistency and predictability, and that agency coordination and use of scientific advisory panels offer less dramatic, but more realistic, approaches for improving the management of risk.

Included in

Law Commons